Each disease area and drug program in our pipeline takes us one step closer to transforming preclinical R&D using computational chemistry to discover small molecule drugs more efficiently than traditional approaches to deliver better medicines, faster.
R & D Pipeline
TOTAL PIPELINE DEPTH
TARGETS WITH VALIDATED HITS
Atomwise has internal drug discovery programs across many disease areas including oncology, immunology, cardiology, neurology, and rare diseases.
Contact us to learn about licensing opportunities.